(19)
(11) EP 1 011 608 A2

(12)

(88) Date of publication A3:
27.01.2000

(43) Date of publication:
28.06.2000 Bulletin 2000/26

(21) Application number: 99930160.9

(22) Date of filing: 08.06.1999
(51) International Patent Classification (IPC)7: A61K 6/00
(86) International application number:
PCT/US9912/775
(87) International publication number:
WO 9963/938 (16.12.1999 Gazette 1999/50)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE

(30) Priority: 08.06.1998 US 88501 P
09.06.1998 US 93972
09.06.1998 US 88657 P

(71) Applicant: Epigenesis Pharmaceuticals, Inc.
Cranbury, NJ 08512 (US)

(72) Inventors:
  • NYCE, Jonathan, W.
    Princeton, NJ 08540 (US)
  • HILL, Jeffrey, L.
    Chapel Hill, NC 27514 (US)

(74) Representative: Straus, Alexander, Dr. Dipl.-Chem. 
PatentanwälteBecker, Kurig, StrausBavariastrasse 7
80336 München
80336 München (DE)

   


(54) COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF CARDIOPULMONARY AND RENAL FAILURE OR DAMAGE ASSOCIATED WITH ISCHEMIA, ENDOTOXIN RELEASE, ARDS OR BROUGHT ABOUT BY ADMINISTRATION OF CERTAIN DRUGS